242 related articles for article (PubMed ID: 31422395)
1. Trimethoprim-sulfamethoxazole Induced Hyponatremia and Hyperkalemia, The Necessity of Electrolyte Follow-up in Every Patient.
Khorvash F; Moeinzadeh F; Saffaei A; Hakamifard A
Iran J Kidney Dis; 2019 Jul; 13(4):277-280. PubMed ID: 31422395
[TBL] [Abstract][Full Text] [Related]
2. Severe hyponatremia and hyperkalemia induced by trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia.
Noto H; Kaneko Y; Takano T; Kurokawa K
Intern Med; 1995 Feb; 34(2):96-9. PubMed ID: 7727887
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Clinical Characteristics of Hyponatremia Induced by Trimethoprim/Sulfamethoxazole.
Lei H; Liu X; Zeng J; Fan Z; He Y; Li Z; Wang C
Pharmacology; 2022; 107(7-8):351-358. PubMed ID: 35381593
[TBL] [Abstract][Full Text] [Related]
4. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole.
Mori H; Kuroda Y; Imamura S; Toyoda A; Yoshida I; Kawakami M; Tabei K
Intern Med; 2003 Aug; 42(8):665-9. PubMed ID: 12924488
[TBL] [Abstract][Full Text] [Related]
5. Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy.
Greenberg S; Reiser IW; Chou SY
Am J Kidney Dis; 1993 Oct; 22(4):603-6. PubMed ID: 8213804
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure.
Tsapepas D; Chiles M; Babayev R; Rao MK; Jaitly M; Salerno D; Mohan S
Am J Med; 2016 Dec; 129(12):1322-1328. PubMed ID: 27542610
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-sulfamethoxazole-induced hyponatremia.
Dunn RL; Smith WJ; Stratton MA
Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
[TBL] [Abstract][Full Text] [Related]
8. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
Yokoyama S; Nakagawa J; Aiuchi N; Seito T; Niioka T
J Clin Pharm Ther; 2022 Sep; 47(9):1409-1417. PubMed ID: 35545234
[TBL] [Abstract][Full Text] [Related]
9. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
[TBL] [Abstract][Full Text] [Related]
10. Hyponatremia Associated With Standard-Dose Trimethoprim-Sulfamethoxazole Use in an Immunocompetent Patient.
Azeem A; Majeed N; Khuwaja S
WMJ; 2022 Oct; 121(3):E57-E59. PubMed ID: 36301661
[TBL] [Abstract][Full Text] [Related]
11. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.
Greenberg S; Reiser IW; Chou SY; Porush JG
Ann Intern Med; 1993 Aug; 119(4):291-5. PubMed ID: 8328737
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia after initiation and rechallenge with trimethoprim-sulfamethoxazole in an older adult.
Huntsberry AM; Linnebur SA; Vejar M
Clin Interv Aging; 2015; 10():1091-6. PubMed ID: 26170649
[TBL] [Abstract][Full Text] [Related]
13. Myelotoxicity and kidney dysfunction related to the use of trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia: a case report of severe adverse events with a common drug.
Mendes ICM; Mamani RF; Coelho DRA; Pimentel C
Rev Inst Med Trop Sao Paulo; 2024; 66():e18. PubMed ID: 38511807
[TBL] [Abstract][Full Text] [Related]
14. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study.
Ohmura SI; Naniwa T; Tamechika SY; Miyamoto T; Shichi D; Kazawa N; Iwagaitsu S; Maeda S; Wada JI; Niimi A
J Infect Chemother; 2019 Apr; 25(4):253-261. PubMed ID: 30642768
[TBL] [Abstract][Full Text] [Related]
17. [Retrospective investigation of side effects and prognoses of moderate-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia that developed in patients with autoimmune diseases].
Shibata T; Tonooka K; Tsuchida K; Mitomi H; Shibata T; Katsuyama N
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):213-8. PubMed ID: 27320937
[TBL] [Abstract][Full Text] [Related]
18. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report.
Baran K; FurmaĆczyk-Zawiska A; Wieczorek-Godlewska R; Nitek P; Durlik M
Transplant Proc; 2024 May; 56(4):1000-1005. PubMed ID: 38760300
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-associated hyponatremia.
Babayev R; Terner S; Chandra S; Radhakrishnan J; Mohan S
Am J Kidney Dis; 2013 Dec; 62(6):1188-92. PubMed ID: 23891358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]